Intech Investment Management LLC Has $1.76 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Intech Investment Management LLC decreased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 86.8% during the third quarter, HoldingsChannel.com reports. The fund owned 23,448 shares of the company’s stock after selling 153,901 shares during the period. Intech Investment Management LLC’s holdings in GE HealthCare Technologies were worth $1,761,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Dodge & Cox boosted its position in GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares during the period. Norges Bank acquired a new stake in shares of GE HealthCare Technologies in the second quarter worth $468,120,000. Holocene Advisors LP boosted its holdings in shares of GE HealthCare Technologies by 178.5% during the 2nd quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after buying an additional 2,581,522 shares during the period. Menora Mivtachim Holdings LTD. acquired a new position in GE HealthCare Technologies in the 2nd quarter valued at $80,755,000. Finally, Balyasny Asset Management L.P. bought a new position in GE HealthCare Technologies in the 2nd quarter worth $58,388,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 2.4%

Shares of GEHC stock opened at $77.11 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $89.77. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The stock has a fifty day moving average price of $81.99 and a 200 day moving average price of $78.53. The stock has a market cap of $35.14 billion, a P/E ratio of 16.91, a price-to-earnings-growth ratio of 1.74 and a beta of 1.03.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. During the same quarter in the prior year, the company posted $1.45 EPS. The business’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is presently 3.07%.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of recent analyst reports. BTIG Research upped their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Stifel Nicolaus lifted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a research report on Wednesday, February 4th. Evercore upped their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Jefferies Financial Group raised their price objective on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Thursday, December 11th. Finally, Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $92.50.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.